| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| SULENTIC ROBERT E | Chair & CEO, Director | 2121 NORTH PEARL STREET, SUITE 300, DALLAS | /s/ Andria Iles, Attorney-in-Fact for Robert E. Sulentic | 27 Feb 2026 | 0001190868 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CBRE | Class A Common Stock | Award | $0 | +40,636 | +3% | $0.000000 | 1,389,384 | 25 Feb 2026 | Direct | F1 |
| transaction | CBRE | Class A Common Stock | Tax liability | $504,444 | -3,426 | -0.25% | $147.24 | 1,385,958 | 25 Feb 2026 | Direct |
| Id | Content |
|---|---|
| F1 | The Issuer granted these securities to the Reporting Person on February 25, 2026 as part of the Reporting Person's 2026 annual equity award. These securities will vest at a rate of 25% per year on each of February 25, 2027, 2028, 2029 and 2030, subject to forfeiture or acceleration in certain circumstances as set forth in the award agreement for these securities. |